Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to Accelerate Global Growth, Product Commercialization and Innovation
- Genexine to focus on global drug development and commercialization - Near term milestones should…
- Genexine to focus on global drug development and commercialization - Near term milestones should…
SEOUL, South Korea--(BUSINESS WIRE)--Genexine (KOSDAQ: 095700), a publicly traded, clinical stage biopharmaceutical company committed to…
ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News: Azelis (Brussels:AZE), a leading global innovation service provider in the specialty…
Travellers can look forward to fresh and innovative experiences, along with exclusive deals. JAKARTA, INDONESIA…
Far-ranging collaboration in next-generation memory software technology aimed at gaining full support throughout the Red…
HONG KONG--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced the final close of KKR…
DALLAS--(BUSINESS WIRE)--IntelliCentrics (6819.HK) the innovator of the SEC³URE Ethos, SEC³URE Passport, Link & GO!, BioBytes™…
Investors and Businesses can now access Data-Driven insights tailored specifically to the Australian Marketplace NEW…
The former Allergan Chairman and CEO and top medical aesthetics expert NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Hugel…
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--#DRREDDY--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY,…